MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bioanalytical Systems Company Profile (NASDAQ:BASI)

Consensus Ratings for Bioanalytical Systems (NASDAQ:BASI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Bioanalytical Systems (NASDAQ:BASI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for Bioanalytical Systems (NASDAQ:BASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/12/2016Q216($0.03)$5.73 million$5.34 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2016Q116($0.06)$5.95 million$4.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/17/2015Q415($0.09)$6.42 million$4.98 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q315$0.16$6.03 million$6.15 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2015Q215($0.01)$5.92 million$5.73 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q115$0.01$6.22 million$5.85 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/22/2014Q414($0.02)$6.42 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2014Q314$0.02$5.60 million$6.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/15/2014Q2($0.03)$5.16 million$5.91 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014Q114$0.04$5.80 million$6.22 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/24/2013Q4 13$0.03$6.54 million$5.51 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2013Q313$0.01$0.07$5.65 million$5.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/15/2013Q2 2013$0.01($0.02)$5.74 million$5.16 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q1 2013($0.03)$0.02$6.65 million$5.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Bioanalytical Systems (NASDAQ:BASI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Bioanalytical Systems (NASDAQ:BASI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Bioanalytical Systems (NASDAQ:BASI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/27/2016Connie Leigh DoughertyVPBuy423$0.92$389.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Connie Leigh DoughertyVPBuy96$0.92$88.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Connie Leigh DoughertyVPBuy1,655$0.92$1,522.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Jacqueline M LemkeCEOBuy10,000$1.18$11,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Philip A DowningVPBuy3,000$1.73$5,190.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Jacqueline M LemkeCEOBuy10,000$2.04$20,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014John P DevineVPSell3,130$2.64$8,263.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2012David L OmachinskiDirectorBuy10,000$1.26$12,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2012Jacqueline M LemkeCEOBuy20,000$1.26$25,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Bioanalytical Systems (NASDAQ:BASI)
DateHeadline
05/18/16 05:53 AMEdited Transcript of BASI earnings conference call or presentation 12-May-16 3:00pm GMT -
05/13/16 10:58 AMBioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q2, 2016 By the Numbers -
05/12/16 08:56 AMBASi Reports Second Quarter Results - [Business Wire] - Bioanalytical Systems, Inc. today announced financial results for the second quarter and first six months of fiscal 2016.
05/12/16 06:07 AMQ2 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open -
05/11/16 10:01 AMBioanalytical Systems, Inc. Announces Appointment of New Chief Financial Officer - [Business Wire] - Bioanalytical Systems, Inc. on May 9, 2016, the Board of Directors of the Company approved the appointment of Jill C. Blumhoff, age 39, as Chief Financial Officer and Vice President of Finance of the Company.
05/04/16 12:16 PMBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex -
05/04/16 09:50 AMBioanalytical Systems to Release Second Quarter Fiscal 2016 Results on Thursday, May 12, 2016; Conference Call & Webcast Set For 11:00 a.m. EDT - [at noodls] - Start Text Here NEWS RELEASE FOR MORE INFORMATION: Company Contact: Jeffrey Potrzebowski Chief Financial Officer Phone: 765.497.8409 ... This is an abstract of the original noodl. To continue reading this ...
04/14/16 01:10 PMBASi Launches New Website and E-Catalogue - [Business Wire] - Bioanalytical Systems, Inc. today announced the launch of a new, redesigned version of its website, www.basinc.com. The site's refreshed and simplified look, combined with enhanced content, improved search functionality, and optimization for mobile devices allows customers and visitors to better interact with BASi online.
03/29/16 12:08 PMCORRECTING and REPLACING BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™ - [Business Wire] - Fourth paragraph, first sentence should read: The Epsilon EClipse™ with vastly improved user friendliness includes a modern Windows® interface, allows for opening an unlimited numb
03/16/16 02:52 PMBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
03/04/16 12:25 PMBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
02/18/16 10:12 AMBioanalytical Systems, Inc. Earnings Analysis: Q1, 2016 By the Numbers -
02/17/16 10:10 AMEdited Transcript of BASI earnings conference call or presentation 16-Feb-16 4:00pm GMT -
02/17/16 09:40 AMBioanalytical Systems Loss Widens in Q1, Revenues Fall -
02/16/16 12:41 PMBioanalytical Systems : BASi Reports First Quarter Results - About Bioanalytical Systems, Inc. BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The Company focuses on ...
02/16/16 12:41 PMBASi Reports Fiscal Q1 Loss - West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting fiscal first quarter net loss of $506,000, compared to a net income of $182,000 during the same period the previous year. Chief Executive Officer Jacqueline Lemke says the company ...
02/16/16 08:00 AMBASi Reports First Quarter Results - [Business Wire] - Bioanalytical Systems, Inc. today announced financial results for the first quarter of fiscal 2016, which resulted in non-compliance with the financial covenants in its credit facility.
02/16/16 06:07 AMQ1 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open -
02/12/16 12:32 PMBasi Awards Three Sampling Systems for Full Animal Response Profiles - WEST LAFAYETTE, Ind., Feb. 12, 2016 — Pharmaceutical development company Bioanalytical Systems Inc. (Basi) has awarded three of its Raturn Swivel-Free Sampling Systems to researchers who will integrate in vivo optogenetic techniques with data collection ...
02/11/16 03:20 PMBioanalytical Systems, Inc.: Gathering momentum, but may lack support -
02/09/16 09:00 AMBioanalytical Systems to Release First Quarter Fiscal 2016 Results on Tuesday, February 16, 2016; Conference Call & Webcast Set For 11:00 a.m. EST - [Business Wire] - Bioanalytical Systems, Inc. announced today that it will report financial results for the first quarter of fiscal 2016 ended December 31, 2015, prior to the market opening on Tuesday, February 16, 2016.
02/04/16 10:50 AMBASi Awards Raturn® Systems for Optogenetic Research - [Business Wire] - Bioanalytical Systems, Inc. today announced it is awarding three BASi Raturn® Swivel-Free Sampling Systems to researchers who will integrate in vivo optogenetics techniques with data collection techniques.
01/31/16 05:47 PMBioanalytical Systems Inc. (BASI) - Bioanalytical Systems to Release Second Quarter Fiscal 2015 Results on Thursday, May 14, 2015; Conference Call & Webcast Set For 11:00 a.m. EDTBusiness Wire (Mon, May 4)
12/31/15 12:04 PMBIOANALYTICAL SYSTEMS INC Financials -
12/24/15 11:27 AMBIOANALYTICAL SYSTEMS INC Files SEC form 10-K, Annual Report -
12/22/15 02:56 PMBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -
12/17/15 08:01 AMBASi Reports Fiscal 2015 Full Year and Fourth Quarter Results - [Business Wire] - Bioanalytical Systems, Inc. today announced financial results for the full fiscal year and fourth quarter ended September 30, 2015.
12/15/15 12:34 PMBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers -
12/15/15 10:00 AMBASi Names Dawn M. Joseph Director of Business Development - [Business Wire] - Bioanalytical Systems, Inc. today announced the appointment of Dawn M. Joseph as Director of Business Development reporting to BASi Vice President of Business Development, Connie Dougherty.
12/14/15 09:30 AMBASi Names Wendy Perrow to Board of Directors - [Business Wire] - Bioanalytical Systems, Inc. today announced that its board of directors unanimously elected Ms. Wendy Perrow, President and Chief Executive Officer at Alba Therapeutics, as a director effective December 10, 2015.
12/03/15 02:45 PMBioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2015 Results on Thursday, December 17, 2015; Conference Call & Webcast Set For 11:00 a.m. EST - [Business Wire] - Bioanalytical Systems, Inc. announced today that it will report financial results for the fourth quarter and full year for the ended September 30, 2015, prior to the market opening on Thursday, December 17, 2015.
11/19/15 03:52 PMBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh -
09/21/15 10:28 AMBioanalytical Systems, Inc. Earnings Q3, 2015 -
08/14/15 02:36 PMBIOANALYTICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report -
08/13/15 07:45 AMBASi Reports Third Quarter Net Income of $0.16 per Share - [Business Wire] - Bioanalytical Systems, Inc. today announced financial results for the third quarter and first nine months of fiscal 2015.
08/10/15 01:56 PMBioanalytical Systems to Release Third Quarter Fiscal 2015 Results on Thursday, August 13, 2015; Conference Call & Webcast Set For 11:00 a.m. EDT - [Business Wire] - Bioanalytical Systems, Inc. announced today that it will report financial results for the third quarter of fiscal 2015 ended June 30, 2015, prior to the market opening on Thursday, August 13, 2015.
About Bioanalytical Systems

Bioanalytical Systems, Inc. (BASi) is a contract research organization (CRO) providing drug discovery and development services and analytical instruments. The Company operates through two segments: contract research services and research products. Its contract research services segment provides research and development support on a contract basis directly to pharmaceutical companies. Its research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Its Culex family of robotic automated dose delivery, blood and other biofluids sampling and physiological parameters measurement systems enable researchers to determine pharmacokinetic/pharmacodynamic (PK/PD) profiles of drugs in large and small animal models. The Company's bioanalytical services group supports research, preclinical and clinical programs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BASI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.17
  • 50 Day Moving Average: $1.01
  • 200 Day Moving Average: $1.20
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $9.49M
  • Current Quarter EPS Consensus Estimate: $0.01 EPS
Additional Links:
Bioanalytical Systems (NASDAQ:BASI) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha